R. Camisasca
R. Camisasca publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology, on topics such as Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer and Diabetes Management and Research.
- World rank
- #1,660,900 of 7,710,434 ranked researchers
- Rank in Switzerland
- #27,110 of 80,918
- Works
- 19
- Citations
- 1.7k
- Citations per work
- 89.1
What does R. Camisasca research?
R. Camisasca's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1366.7%
- Medicine1366.7%
- Everything else423.5%
- Life Sciences29.8%
- 1Endocrinology, Diabetes and Metabolism35% of their works
- 2Cardiology and Cardiovascular Medicine22% of their works
- 3Molecular Biology10% of their works
- 4Physiology4% of their works
- 5Surgery4% of their works
- 6Pharmacology2% of their works
Research topics
- Diabetes Treatment and Management
- Metabolism, Diabetes, and Cancer
- Diabetes Management and Research
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
- Cardiovascular Function and Risk Factors
- Growth Hormone and Insulin-like Growth Factors
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe R. Camisasca's research?
The keywords of their largest research topics: Cardiovascular Disease, Diabetes, Glycemic Control, Insulin Therapy, Clinical Guidelines, Heart Failure, Hypertension and Cardiovascular Outcomes.
- Metabolic Syndrome
- Insulin Resistance
- Echocardiography
- Renin
- Antihypertensive Drugs
- Obesity
- Hypoglycemia
- AMP-Activated Protein Kinase
- Cardiovascular Outcomes
- Heart Failure
- Insulin Therapy
- Diabetes
- Cardiovascular Disease
- Glycemic Control
- Clinical Guidelines
- Hypertension
- Type 2 Diabetes
- Continuous Glucose Monitoring
- Metformin
- Angiotensin
- Blood Pressure
- Chamber Quantification
- IGF-1
- Insulin-like Growth Factors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Cardiovascular Disease124 topics
- Diabetes93 topics
- Glycemic Control92 topics
- Insulin Therapy92 topics
- Clinical Guidelines82 topics
- Heart Failure72 topics
- Hypertension62 topics
- Cardiovascular Outcomes51 topic
- Type 2 Diabetes51 topic
- AMP-Activated Protein Kinase41 topic
- Continuous Glucose Monitoring41 topic
- Hypoglycemia41 topic
- Metformin41 topic
- Obesity42 topics
- Angiotensin31 topic
- Antihypertensive Drugs31 topic
- Blood Pressure31 topic
- Renin31 topic
- Chamber Quantification21 topic
- Echocardiography21 topic
- IGF-121 topic
- Insulin Resistance21 topic
- Insulin-like Growth Factors21 topic
- Metabolic Syndrome21 topic
Where does R. Camisasca work?
R. Camisasca's main affiliation in the publication record is Novartis (Switzerland), Switzerland.
How many publications and citations does R. Camisasca have?
OpenAlex counts 19 works and 1,693 citations for R. Camisasca, an h-index of 11, ranking #1,660,900 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about R. Camisasca. Posts are plain text and can be reported.